Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
5.71
-0.11 (-1.89%)
At close: Sep 16, 2025, 4:00 PM EDT
5.58
-0.13 (-2.28%)
After-hours: Sep 16, 2025, 5:30 PM EDT
AVR Market Cap
AVR has a market cap or net worth of $200.88 million as of September 16, 2025. Its market cap has decreased by -8.21% in one year.
Market Cap
200.88M
Enterprise Value
174.42M
1-Year Change
-8.21%
Ranking
Category
Stock Price
5.71
Market Cap Chart
Since the IPO on October 23, 2017, AVR's market cap has increased from $49.67M to $200.88M, an increase of 304.42%. That is a compound annual growth rate of 19.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 194.68M | 5.84% |
| Dec 31, 2024 | 183.94M | -20.93% |
| Dec 29, 2023 | 232.62M | 10.90% |
| Dec 30, 2022 | 209.76M | 100.65% |
| Dec 31, 2021 | 104.54M | 525.78% |
| Dec 22, 2020 | 16.71M | -59.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |